Panagora Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,755
| Closed | -$678K | – | 1348 |
|
|
2023
Q1 | $678K | Sell |
17,755
-7,625
| -30% | -$358K | ﹤0.01% | 1001 |
|
|
2022
Q4 | $1.44M | Sell |
25,380
-8,164
| -24% | -$418K | 0.01% | 741 |
|
|
2022
Q3 | $1.33M | Hold |
33,544
| – | – | 0.01% | 750 |
|
|
2022
Q2 | $1.48M | Buy |
33,544
+4
| +0% | +$173 | 0.01% | 730 |
|
|
2022
Q1 | $1.34M | Hold |
33,540
| – | – | 0.01% | 816 |
|
|
2021
Q4 | $1.35M | Sell |
33,540
-241
| -0.7% | -$9K | 0.01% | 795 |
|
|
2021
Q3 | $1.37M | Hold |
33,781
| – | – | 0.01% | 821 |
|
|
2021
Q2 | $1.53M | Sell |
33,781
-13,799
| -29% | -$611K | 0.01% | 802 |
|
|
2021
Q1 | $1.98M | Sell |
47,580
-2,308
| -5% | -$105K | 0.01% | 743 |
|
|
2020
Q4 | $2.13M | Sell |
49,888
-16,454
| -25% | -$591K | 0.01% | 689 |
|
|
2020
Q3 | $1.74M | Sell |
66,342
-223,628
| -77% | -$6.23M | 0.01% | 703 |
|
|
2020
Q2 | $7.77M | Sell |
289,970
-559,895
| -66% | -$12.6M | 0.05% | 299 |
|
|
2020
Q1 | $15.3M | Sell |
849,865
-503,076
| -37% | -$9.55M | 0.11% | 182 |
|
|
2019
Q4 | $24M | Buy |
1,352,941
+108,275
| +9% | +$1.88M | 0.11% | 193 |
|
|
2019
Q3 | $19.3M | Sell |
1,244,666
-65,293
| -5% | -$1.08M | 0.09% | 211 |
|
|
2019
Q2 | $22.5M | Buy |
1,309,959
+81,579
| +7% | +$1.32M | 0.1% | 203 |
|
|
2019
Q1 | $19.8M | Buy |
1,228,380
+228,321
| +23% | +$3.7M | 0.09% | 234 |
|
|
2018
Q4 | $14.6M | Buy |
1,000,059
+12,192
| +1% | +$194K | 0.07% | 249 |
|
|
2018
Q3 | $17.9M | Buy |
987,867
+109,088
| +12% | +$1.91M | 0.07% | 250 |
|
|
2018
Q2 | $14.8M | Buy |
878,779
+145,012
| +20% | +$2.74M | 0.06% | 271 |
|
|
2018
Q1 | $14.4M | Sell |
733,767
-80,475
| -10% | -$1.56M | 0.06% | 275 |
|
|
2017
Q4 | $16.5M | Sell |
814,242
-42,337
| -5% | -$778K | 0.06% | 280 |
|
|
2017
Q3 | $14.9M | Sell |
856,579
-22,664
| -3% | -$307K | 0.06% | 309 |
|
|
2017
Q2 | $11.3M | Sell |
879,243
-1,115
| -0.1% | -$14.9K | 0.05% | 374 |
|
|
2017
Q1 | $11.4M | Buy |
880,358
+24,351
| +3% | +$308K | 0.05% | 382 |
|
|
2016
Q4 | $8.46M | Buy |
856,007
+58,926
| +7% | +$645K | 0.04% | 411 |
|
|
2016
Q3 | $9.63M | Sell |
797,081
-187,642
| -19% | -$1.92M | 0.05% | 370 |
|
|
2016
Q2 | $8.5M | Buy |
984,723
+242,213
| +33% | +$2.39M | 0.04% | 401 |
|
|
2016
Q1 | $7.03M | Buy |
742,510
+99,396
| +15% | +$935K | 0.03% | 463 |
|
|
2015
Q4 | $11.1M | Buy |
643,114
+44,901
| +8% | +$716K | 0.05% | 325 |
|
|
2015
Q3 | $8.03M | Buy |
598,213
+12,013
| +2% | +$241K | 0.04% | 387 |
|
|
2015
Q2 | $13.2M | Sell |
586,200
-37,562
| -6% | -$660K | 0.07% | 307 |
|
|
2015
Q1 | $8.91M | Buy |
623,762
+124,352
| +25% | +$1.79M | 0.05% | 364 |
|
|
2014
Q4 | $4.82M | Buy |
499,410
+27,926
| +6% | +$248K | 0.02% | 480 |
|
|
2014
Q3 | $4.29M | Sell |
471,484
-14,261
| -3% | -$136K | 0.02% | 531 |
|
|
2014
Q2 | $4.8M | Buy |
485,745
+187,354
| +63% | +$1.59M | 0.02% | 530 |
|
|
2014
Q1 | $3.79M | Buy |
298,391
+43,200
| +17% | +$641K | 0.02% | 646 |
|
|
2013
Q4 | $3.83M | Buy |
255,191
+227,913
| +836% | +$2.93M | 0.02% | 619 |
|
|
2013
Q3 | $301K | Hold |
27,278
| – | – | ﹤0.01% | 1510 |
|
|
2013
Q2 | $216K | Buy |
+27,278
| New | +$174K | ﹤0.01% | 1599 |
|
Other funds holding HALO
SCM
GKIM
Panagora Asset Management's HALO Position: Q2 2023 in Review
Panagora Asset Management sold out of Halozyme (HALO) in Q2 2023, closing a stake of 17,755 shares — an estimated $678K sold.
Panagora Asset Management first reported a position in HALO in Q2 2013 and held it in 40 quarters. The position peaked at $24M in Q4 2019. 370 funds tracked by Wall St. Rank hold HALO as of Q2 2023.
- Panagora Asset Management reported no remaining Halozyme position as of Q2 2023 after selling out during the quarter.
- Panagora Asset Management sold 17,755 Halozyme shares in Q2 2023, an estimated $678K.
- Panagora Asset Management first reported a position in Halozyme in Q2 2013 and held it in 40 quarters.
- Panagora Asset Management's Halozyme position peaked at $24M in Q4 2019.
- 370 funds tracked by Wall St. Rank held Halozyme as of Q2 2023.
Based on Panagora Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.